CD4 and AIDS: CD8+ T cell activation is enhanced in INR individuals compared to clinical responders (CRs) who achieve a higher blood CD4+ T cell count during ART (8), and while the INR phenotype is incompletely understood this chronic immune activation may be why these individuals are at a higher risk of serious non-AIDS co-morbidities and mortality (9–11).